Johnson & Johnson: Urinary Tract Infections trials

The registry lists 10 Urinary Tract Infections studies with Johnson & Johnson as lead sponsor. 0 are open to participants now and 3 have results posted.

Phase 3 6Phase 4 2No phase 2(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• A Safety and Tolerability Study of Doripenem Compared With Cefepime in Children Hospitalized With Complicated Urinary Tract InfectionsTerminatedNCT01110408Phase 3Results posted
• PROUD Study: A Prospective Study on the Usage Patterns of Doripenem in the Asia Pacific RegionCompletedNCT00986102Phase 4Results posted
• A Safety and Efficacy Study of Doripenem in Participants With Nosocomial Pneumonia, Complicated Intra-Abdominal Infections and Urinary Tract InfectionsCompletedNCT00965848Phase 4Results posted
• Fluoroquinolone Associated DisabilityCompletedNCT03535558
• A Study of the Safety and Effectiveness of Doripenem in Filipino Patients With Nosocomial Pneumonia, Complicated Intra-Abdominal Infections and Complicated Urinary Tract InfectionsCompletedNCT01763008
• A Study of the Safety and Effectiveness of Levofloxacin Compared With Lomefloxacin in the Treatment of Complicated Urinary Tract InfectionsCompletedNCT00258102Phase 3
• A Study of the Safety and Effectiveness of Oral Levofloxacin Compared With Oral Ciprofloxacin in the Treatment of Complicated Urinary Tract InfectionsCompletedNCT00258089Phase 3
• Doripenem in the Treatment of Complicated Lower Urinary Tract Infection or PyelonephritisCompletedNCT00229021Phase 3
• Doripenem in the Treatment of Complicated Lower Urinary Tract Infection or PyelonephritisCompletedNCT00210990Phase 3
• A Comparison of the Effectiveness and Safety of Levofloxacin to That of Ciprofloxacin in Treating Complicated Urinary Tract Infection and Acute Pyelonephritis.CompletedNCT00210886Phase 3